Wegovy ( Semaglutide) is way ahead of all the FDA-approved weight loss medicines until now.
However, Tirzepatide is going to be a tough competitor.
In clinical trials, it is associated with upto 22.5 % weight loss.
Read More @ https://dibesity.com/lillys-tirzepatide-exceptional-weight-loss-results/
Tirzepatide got FDA approved by the brand name of Mounjaro.
Mounjaro injection is a trademark of Eli Lilly. It is indicated for the treatment of patients with T2DM.
Although, it has not yet been approved for the treatment of obesity, in clinical trials, it has superior weight loss effects when compared with Semaglutide.